<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-5-54</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-5-7-8</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Headache</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Chocolate is a Migraine-Provoking Agent</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>07</month>
<year>1991</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>07</month>
<year>2016</year>
</pub-date>
<volume>5</volume>
<issue>7</issue>
<fpage>54</fpage>
<lpage>55</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 1991 The Author(s)</copyright-statement>
<copyright-year>1991</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1046/j.1468-2982.1991.1102093.x" vol="11" page="93">
<article-title>Chocolate is a migraine-provoking agent</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>Patients with migraine who believe that chocolate could provoke their attacks were challenged with either chocolate or a closely matching placebo in a double-blind parallel group study at the Princess Margaret Migraine Clinic, Charing Cross Hospital, London, England.</p>
</abstract>
<kwd-group>
<kwd>Chocolate</kwd>
<kwd>Migraine</kwd>
<kwd>Catechin</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Patients with migraine who believe that chocolate could provoke their attacks were challenged with either chocolate or a closely matching placebo in a double-blind parallel group study at the Princess Margaret Migraine Clinic, Charing Cross Hospital, London, England. The placebo contained no cocoa butter or cocoa powder and the carob powder used in the placebo was also added to the chocolate and successfully disguised by the use of a peppermint-masking flavor. The two groups of patients, all adults, were matched for age and sex and all were drug-free for at least 48 hours prior to investigation. Chocolate ingestion (40 gram bar) was followed by a typical migraine episode in 5 out of 12 patients, while none of the 8 patients challenged with placebo had an attack (P=.051). The median time interval to onset of symptoms following chocolate consumption was 22 hours (range 3.5-27 hours). [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<disp-quote>
<p><bold>COMMENT.</bold> In a double-blind challenge study in children referred with severe headache, 82 of 99 patients responded to an oligoantigenic diet [<xref ref-type="bibr" rid="CIT0002">2</xref>]. Relapses occurred in 74 on the introduction of one or more food stuffs, with chocolate provoking attacks in 30%. Methyl-zanthine, theobromine and phenolic compounds including catechin are some pharmacologically active compounds found in relatively large amounts in chocolate. The relevant chemical agent responsible for initiating a migraine attack requires to be elucidated. My own clinical experience in children suggests that chocolate is a common precipitating factor in migraine susceptible patients. The effects of eliminating chocolate and caffeine containing drinks should be investigated before long-term drug treatment is considered.</p>
</disp-quote>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gibb</surname>
<given-names>C.M</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>F.C</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Glover</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Steiner</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Sandler</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Chocolate is a migraine-provoking agent</article-title>
<source>Cephalalgia</source>
<year>1991</year>
<month>May</month>
<volume>11</volume>
<issue>2</issue>
<fpage>93</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1046/j.1468-2982.1991.1102093.x</pub-id>
<pub-id pub-id-type="pmid">1860135</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egger</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Soothill</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Is migraine food allergy? A double-blind controlled trial of oligoantigenic diet treatment</article-title>
<source>Lancet</source>
<year>1983</year>
<month>Oct</month>
<volume>2</volume>
<issue>8355</issue>
<fpage>865</fpage>
<lpage>869</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(83)90866-8</pub-id>
<pub-id pub-id-type="pmid">6137694</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>